Idamycin Related Clinical Trials
Clofarabine Combinations in Relapsed/Refractory AML, MDS and Myeloid Blast Phase CML [Recruiting]
Phase I Using Velcade & Idarubicin in Elderly and Relapsed AML [Recruiting]
Standard Idarubicin and Cytarabine for the Treatment of Acute Myeloid Leukemia (AML) [Recruiting]
Idarubicin and Cytarabine With or Without Bevacizumab in Treating Patients With Newly Diagnosed Acute Myeloid Leukemia [Completed]
Phase II Study of Idarubicin, Cytarabine, and Vorinostat in Patients With High-Risk MDS and AML [Recruiting]
Dosing Study of Ara-C/EL625/Idarubicin in Refractory and Relapsed AML [Completed]
Pravastatin, Idarubicin, and Cytarabine in Treating Patients With Acute Myeloid Leukemia [Active, not recruiting]
VELCADE in Combination With Idarubicin and Cytosine Arabinoside in Patients With Acute Myelogenous Leukemia [Active, not recruiting]
Idarubicin, Cytarabine, and Tipifarnib in Treating Patients With Newly Diagnosed Myelodysplastic Syndromes or Acute Myeloid Leukemia [Active, not recruiting]
Idarubicin, Cytarabine, and Gemtuzumab Ozogamicin in Treating Patients With Previously Untreated High-Risk Myelodysplastic Syndrome or Acute Myeloid Leukemia Secondary to Myelodysplastic Syndrome [Active, not recruiting]
Bevacizumab, Idarubicin, and Cytarabine in Treating Patients With Blast Phase Chronic Myelogenous Leukemia [Completed]
Salvage Therapy With Idarubicin in Relapsing CNS Lymphoma [Recruiting]
Vorinostat and Idarubicin in Treating Patients With Relapsed or Refractory Leukemia or Myelodysplastic Syndromes [Recruiting]
Phase I-II Study of Idarubicin, Cytarabine, and Sorafenib (BAY43-9006) [Recruiting]
Idarubicin Based Combined Modality Therapy in Primary CNS Lymphoma [Active, not recruiting]
Idarubicin and High-Dose Cytarabine in Treating Patients With Acute Myeloid Leukemia [Recruiting]
Arsenic Trioxide, Cytarabine, and Idarubicin in Treating Patients With Acute Myeloid Leukemia [Recruiting]
Tretinoin and Arsenic Trioxide With or Without Idarubicin in Treating Patients With Acute Promyelocytic Leukemia [Recruiting]
Study Evaluating the Addition of Amifostine (Ethyol®) to Idarubicin and Cytosine Arabinoside in Older Patients With Acute Myeloid Leukemia [Active, not recruiting]
Thalidomide, Cyclophosphamide, Oral Idarubicin and Dexamethasone (T-CID) in Patients With Multiple Myeloma [Recruiting]
Lestaurtinib, Cytarabine, and Idarubicin in Treating Younger Patients With Relapsed or Refractory Acute Myeloid Leukemia [Recruiting]
Treatment of Newly Diagnosed Patients With Acute Promyelocytic Leukemia (PETHEMA LPA 2005) [Recruiting]
Treatment of Acute Promyelocytic Leukemia With All-Trans Retinoic Acid (ATRA) and Idarubicin (AIDA) [Completed]
Combination Chemotherapy With or Without Idarubicin and Peripheral Stem Cell Transplantation in Treating Patients With Leukemia or Myelodysplastic Syndrome [Active, not recruiting]
Amifostine and Combination Chemotherapy in Treating Patients With Newly Diagnosed Acute Myeloid Leukemia [Completed]
Chemotherapy in Treating Patients With Newly Diagnosed Acute or Chronic Myelogenous Leukemia or Myelodysplastic Syndrome [Active, not recruiting]
Combination Chemotherapy in Treating Patients With Relapsed Acute Myelogenous Leukemia [Active, not recruiting]
All-Trans Retinoic Acid in Combination With Standard Induction and Consolidation Therapy in Older Patients With Newly Diagnosed Acute Myeloid Leukemia [Active, not recruiting]
Cladribine, Cytarabine and Idarubicin in Patients With Relapsed Acute Myelocytic Leukemia (AML) [Recruiting]
Combination Chemotherapy in Treating Children With Relapsed or Refractory Acute Lymphocytic Leukemia [Active, not recruiting]
Chemotherapy Plus Steroid Therapy in Treating Patients With Multiple Myeloma [Active, not recruiting]
Combination Chemotherapy in Treating Older Patients With Acute Myeloid Leukemia [Active, not recruiting]
High Dose Chemotherapy, Peripheral Stem Cell Transplantation, and Interleukin-2 in Treating Patients With Acute Myeloid Leukemia [Active, not recruiting]
Combination Chemotherapy With or Without Bone Marrow Transplantation in Treating Patients With Acute Promyelocytic Leukemia [Active, not recruiting]
Combination Chemotherapy Plus Biological Therapy in Treating Patients With Acute Myelogenous Leukemia [Active, not recruiting]
Combination Chemotherapy With or Without Interferon Alfa in Treating Patients With Low-Grade Non-Hodgkin's Lymphoma [Active, not recruiting]
A Randomized Study of Post-Remission Therapy in Elderly Patients With Acute Myelogenous Leukemia. [Terminated]
Velcaflagida in Relapsed or Refractary Acute Myeloid Leukemia [Not yet recruiting]
Treatment of the Acute Myeloblastic Leukaemia in Patients Over 65 Years [Completed]
SMD_FLAG-IDA_98: FLAG-IDA in Induction Treatment of High Risk Myelodysplastic Syndromes or Secondary Acute Myeloblastic Leukemia [Active, not recruiting]
Lomustine and Intermediate Dose Cytarabine in Older Patients With AML [Completed]
Chemotherapy and Biological Therapy With or Without Bone Marrow or Peripheral Stem Cell Transplant in Treating Patients With Chronic Myelogenous Leukemia [Active, not recruiting]
AIDA2000 - Risk-Adapted Therapy for Patients With Acute Promyelocytic Leukemia [Recruiting]
Efficacy of G-CSF-Priming in Elderly AML Patients [Recruiting]
Bortezomib and Combination Chemotherapy in Treating Younger Patients With Recurrent, Refractory, or Secondary Acute Myeloid Leukemia [Recruiting]
FLAG+Ida With G-CSF Priming for Patients Younger Than 60 Years With Resistant AML [Recruiting]
Peripheral Stem Cell Transplantation Plus Filgrastim in Treating Patients With Acute or Chronic Myelogenous Leukemia [Active, not recruiting]
Combination Chemotherapy in Treating Patients With Lymphoma
Interferon-Alfa With or Without Chemotherapy and Peripheral Stem Cell Transplantation in Treating Patients With Newly Diagnosed Chronic Myelogenous Leukemia [Active, not recruiting]
Combination Chemotherapy With or Without Peripheral Stem Cell Transplantation in Treating Patients With Myelodysplastic Syndrome or Acute Myelogenous Leukemia [Active, not recruiting]
Combination Chemotherapy in Treating Children With Very High Risk Acute Lymphocytic Leukemia [Active, not recruiting]
Donor Lymphocytes to Prevent Graft-Versus-Host Disease in Patients With Chronic Myeloid Leukemia [No longer recruiting]
Intensive Compared With Nonintensive Chemotherapy in Treating Older Patients With Acute Myeloid Leukemia or Myelodysplastic Syndrome [Active, not recruiting]
Gemtuzumab Ozogamicin With or Without Chemotherapy in Treating Older Patients With Acute Myeloid Leukemia [Active, not recruiting]
Combination Chemotherapy in Treating Patients With Stage II or Stage III Multiple Myeloma [Recruiting]
Chemotherapy Followed by Peripheral Stem Cell Transplantation in Treating Patients With Myelofibrosis [No longer recruiting]
Chemotherapy Plus Monoclonal Antibody in Treating Patients With Acute Promyelocytic Leukemia [No longer recruiting]
Chemotherapy With or Without Gemtuzumab Ozogamicin in Treating Older Patients With Acute Myeloid Leukemia [Active, not recruiting]
Risk-Adapted Therapy of Acute Myeloid Leukemia of Adults (18-60 Years) According to the Cytogenetic Result [No longer recruiting]
German Multicenter Trial for Treatment of Newly Diagnosed Acute Lymphoblastic Leukemia in Adults (06/99) [Completed]
Treatment of Elderly Patients (>65 Years) With Acute Lymphoblastic Leukemia [Completed]
Treatment of Adults Aged Up to 60 Years With De Novo Acute Myeloblastic Leukaemia,Secondary AML, or RAEB-T [Active, not recruiting]
Combination Chemotherapy Followed by Peripheral Stem Cell Transplantation in Treating Patients With Chronic Myelogenous Leukemia [Active, not recruiting]
Chemotherapy, Interferon, and Bone Marrow Transplantation in Treating Patients With Chronic Myelogenous Leukemia [No longer recruiting]
Combination Chemotherapy, Biological Therapy, and Bone Marrow Transplantation in Treating Patients With Acute Myeloid Leukemia [Active, not recruiting]
Combination Chemotherapy in Treating Patients With Relapsed or Refractory Acute Lymphocytic Leukemia [Active, not recruiting]
Combination Chemotherapy Followed by Bone Marrow or Peripheral Stem Cell Transplantation in Treating Patients With Acute Myelogenous Leukemia [Active, not recruiting]
Combination Chemotherapy in Treating Patients With Intermediate-Grade or Immunoblastic Non-Hodgkin's Lymphoma [Completed]
Combination Chemotherapy With or Without G-CSF in Treating Older Patients With Acute Myeloid Leukemia [Active, not recruiting]
Combination Chemotherapy in Treating Children With Newly Diagnosed Acute Myeloid Leukemia or Myelodysplastic Syndrome [Active, not recruiting]
Monoclonal Antibody Therapy and Chemotherapy in Treating Patients With Acute Promyelocytic Leukemia in Remission
Combination Chemotherapy in Treating Children With Acute Lymphocytic Leukemia [Completed]
Combination Chemotherapy in Treating Children With Relapsed Acute Lymphoblastic Leukemia [Active, not recruiting]
Adding Lomustine to Chemotherapy in Older Patients With Acute Myelogenous Leukemia (AML), and Allogeneic Transplantation for Patients From 60 to 65 Years Old [Recruiting]
Combination Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Patients With Chronic Myelogenous Leukemia or Acute Leukemia [Completed]
Use of the MiCK Assay for Apoptosis in AML [Recruiting]
Combination Chemotherapy With or Without Imatinib Mesylate and/or Peripheral Stem Cell Transplant in Treating Patients With Acute Lymphoblastic Leukemia [Recruiting]
Study on All-Trans Retinoic Acid, Induction and Consolidation Therapy, and Pegfilgrastim After Consolidation Therapy in Younger Patients With Newly Diagnosed Acute Myeloid Leukemia [Recruiting]
German Multicenter Trial for Treatment of Elderly Patients With Newly Diagnosed Acute Lymphoblastic Leukemia [Recruiting]
German Multicenter Trial for Treatment of Newly Diagnosed Acute Lymphoblastic Leukemia in Adults (07/2003) [Recruiting]
Combination Chemotherapy Followed By Stem Cell Transplant in Treating Young Patients With Progressive or Relapsed Anaplastic Large Cell Lymphoma [Recruiting]
Combination Chemotherapy in Treating Patients With Newly Diagnosed Acute Promyelocytic Leukemia [Recruiting]
Study Comparing Imatinib With Chemotherapy as Induction in Elderly Patients With Philadelphia Positive Acute Lymphoblastic Leukemia (ALL) [Recruiting]
Study of XIAP Antisense Given With Chemotherapy for Refractory/Relapsed AML [Recruiting]
Acute Promyelocytic Leukemia 2006 (APL) [Recruiting]
A Remission Induction Therapy and Risk-Oriented Postremission Strategy for Adult Acute Myelogenous Leukemia (AML) [Recruiting]
A Phase I/II Study of CP-4055 in Patients With Refractory/Relapsed Hematologic Malignancies [Recruiting]
|
